Related Experiment Videos
Somatic gene therapy into hematopoietic cells. Current status and future implications
1Division of Neonatology, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis.
Clinics in Perinatology
|March 1, 1993
Summary
Retroviral gene transfer effectively introduces genes into hematopoietic cells, showing progress in efficiency and human trials. Further research is needed for stem cell expansion and enhanced in vivo expression.
Area of Science:
- Hematology
- Gene Therapy
- Molecular Biology
Background:
- Retroviral gene transfer is a key method for gene delivery into hematopoietic cells.
- Significant advancements in retroviral gene transfer technology have occurred over the last seven years.
- Improved transduction efficiency and expression have been observed in animal models, with some applications in human trials.
Purpose of the Study:
- To highlight the progress and current status of retroviral-mediated gene transfer in hematopoietic cells.
- To identify critical areas requiring further research and development in the field.
Main Methods:
- Review of advancements in retroviral vector development.
- Analysis of transduction efficiency and gene expression in preclinical and clinical studies.
- Identification of challenges in hematopoietic stem cell manipulation.
Main Results:
- Demonstrated improvements in transduction efficiency and gene expression.
- Successful application in selected human trials.
- Progress in understanding retroviral vector capabilities.
Conclusions:
- Retroviral gene transfer is a powerful tool for hematopoietic cell modification.
- Further research is essential for in vitro expansion of pluripotent hematopoietic stem cells.
- Development of retroviral vectors for maximized in vivo expression in target cells is crucial.